✦ LIBER ✦

Could intensified treatment in childhood acute lymphoblastic leukemia improve outcome independently of risk factors?

✍ Scribed by Fotini Tzortzatou-Stathopoulou; Maria A. Moschovi; Athina L. Papadopoulou; Ioanna G. Barbounaki; George I. Lambrou; Myrsini Balafouta; Vassiliki Syriopoulou

Book ID: 114792928
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 177 KB
Volume: 75
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2005.00527.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYP3A5andNAT2gene polymorphisms: role in

CYP3A5andNAT2gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome

✍ Vanessa S. Silveira; Renata Canalle; Carlos Alberto Scrideli; Rosane G. P. Queir 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 226 KB

Bone marrow fibrosis in childhood acute

Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome

✍ Norén-Nyström, U; Roos, G; Bergh, A; Botling, J; Lönnerholm, G; Porwit, A; Heyma 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 329 KB

History of treatment and long-term outco

History of treatment and long-term outcome of childhood acute lymphoblastic leukemia in Slovenia

✍ S. Avcin; T. Prelog; M. Kavcic; L. Kitanovski; J. Anzic; M. Benedik Dolnicar; V. 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 237 KB

The pharmacogenetic evaluation of the tr

The pharmacogenetic evaluation of the treatment outcomes in patients with childhood acute lymphoblastic leukemia

✍ N. Karas Kuzelicki; J. Jazbec; I. Mlinaric Rascan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Treatment results in childhood acute lym

Treatment results in childhood acute lymphoblastic leukemia with a modified ALL-BFM’90 protocol: lack of improvement in high-risk group

✍ Federico Sackmann-Muriel; Marı́a Sara Felice; Pedro Alberto Zubizarreta; Elizabe 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Improvement in CNS protective treatment

Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group

✍ Tsurusawa, Masahito; Katano, Naoyuki; Yamamoto, Yoshifumi; Hirota, Takahisa; Koi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 3 views

Background. Prevention of central nervous system (CNS) leukemia by early introduction of therapy to this sanctuary site is an essential component of modern treatment strategy for acute lymphoblastic leukemia (ALL). However, the optimal form of preventive CNS therapy remains debatable. Procedure. To